Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Storz, Peter

Mayo Clinic Jacksonville
United States

Deiminated molecules as markers for developing pancreatic cancer - A1 1R21CA279916-01A1 Matthew Young, Ph.D.
Suga, Jennifer Marie

Kaiser Foundation Research Institute
United States

Kaiser Permanente NCI National Community Oncology Research Program, NCORP 5UG1CA189821-11 Vanessa A. White, M.P.H.
Sukumar, Saraswati

Johns Hopkins University
United States

Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership 5R01CA278816-02 Matthew Young, Ph.D.
Sun, Ju

University Of Minnesota
United States

SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data 5R01CA287413-02 Amanda Skarlupka, Ph.D.
Suter, Melissa J

Massachusetts General Hospital
United States

Early Detection and Diagnosis of Lung Cancer with Endomicroscopy 5R01CA255326-03 Guillermo Marquez, Ph.D.
Svatek, Robert Scott

University Of Texas Hlth Science Center
United States

eRapa for bladder cancer prevention 5R01CA252057-05 PAR-19-183 (R01 Clinical Trial Optional) Howard L. Parnes, M.D.
Tabung, Fred Kinyuy

Ohio State University
United States

Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients 1R21CA294050-01 Amit Kumar, Ph.D.
Tamrazi, Benita

Children'S Hospital Of Los Angeles
United States

Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors 5R21CA262978-02 Rachel Altshuler, Ph.D.
Tanasova, Marina

Michigan Technological University
United States

Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications 2R15CA242401-02A1 Wendy Wang, Ph.D., M.Sc.
Tangen, Catherine M.

Fred Hutchinson Cancer Center
United States

PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research 5U01CA182883-11 Howard L. Parnes, M.D.